Cargando…

The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis

A replication-incompetent hemagglutinating virus of Japan (HVJ) envelope (HVJ-E) induces apoptosis selectively in cancer cells. Fragments of the viral RNA genome transported by HVJ-E are recognized by retinoic acid-inducible gene I (RIG-I) and mitochondrial antiviral signaling (MAVS). Specific pro-a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kaneda, Yasufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654583/ https://www.ncbi.nlm.nih.gov/pubmed/23734313 http://dx.doi.org/10.4161/onci.23566

Ejemplares similares

Breaking tumor-induced immunosuppression with 5′-triphosphate siRNA silencing TGFβ and activating RIG-I
por: Schnurr, Max, et al.
Publicado: (2013)

MAVS integrates glucose metabolism and RIG-I-like receptor signaling
por: He, Qiao-qiao, et al.
Publicado: (2023)

Characterization of the Mollusc RIG-I/MAVS Pathway Reveals an Archaic Antiviral Signalling Framework in Invertebrates
por: Huang, Baoyu, et al.
Publicado: (2017)

The VP3 Protein of Bluetongue Virus Associates with the MAVS Complex and Interferes with the RIG-I-Signaling Pathway
por: Pourcelot, Marie, et al.
Publicado: (2021)

RIG-I Signaling via MAVS Is Dispensable for Survival in Lethal Influenza Infection In Vivo
por: Wu, Wenxin, et al.
Publicado: (2018)

ROS signaling during granzyme B-mediated apoptosis
por: Martinvalet, Denis
Publicado: (2015)

Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE
por: Kronborg Hansen, Anne K., et al.
Publicado: (2022)

Human Cancer Cells Sense Cytosolic Nucleic Acids Through the RIG-I–MAVS Pathway and cGAS–STING Pathway
por: Qiao, Yuan, et al.
Publicado: (2021)

Zyxin stabilizes RIG-I and MAVS interactions and promotes type I interferon response
por: Kouwaki, Takahisa, et al.
Publicado: (2017)

RIG-I Promotes Cell Death in Hepatocellular Carcinoma by Inducing M1 Polarization of Perineal Macrophages Through the RIG-I/MAVS/NF-κB Pathway
por: Zhou, Bei, et al.
Publicado: (2020)

MHC-I genotype drives early immune selection of oncogenic mutations
por: Marty, Rachel, et al.
Publicado: (2018)

Sometimes even apoptosis fails: implications for cancer
por: Berthenet, Kevin, et al.
Publicado: (2020)

Application of iPS cell-derived macrophages to cancer therapy
por: Senju, Satoru, et al.
Publicado: (2014)

Both STING and MAVS Fish Orthologs Contribute to the Induction of Interferon Mediated by RIG-I
por: Biacchesi, Stéphane, et al.
Publicado: (2012)

Naringenin Improves Innate Immune Suppression after PRRSV Infection by Reactivating the RIG-I-MAVS Signaling Pathway, Promoting the Production of IFN-I
por: Yu, Jiaying, et al.
Publicado: (2023)

PNP inhibitors selectively kill cancer cells lacking SAMHD1
por: Davenne, Tamara, et al.
Publicado: (2020)

RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
por: Fischer, Julius C., et al.
Publicado: (2017)

Autoimmunity gene IRGM suppresses cGAS‐STING and RIG‐I‐MAVS signaling to control interferon response
por: Jena, Kautilya Kumar, et al.
Publicado: (2020)

Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016)

Pinched by RNA “fingers”: Long noncoding RNAs hitting signal transduction pathways
por: Liu, Bodu, et al.
Publicado: (2016)

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
por: Peng, Weiyi, et al.
Publicado: (2013)

Activation of RIG-I-Mediated Antiviral Signaling Triggers Autophagy Through the MAVS-TRAF6-Beclin-1 Signaling Axis
por: Lee, Na-Rae, et al.
Publicado: (2018)

The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation
por: Nakhaei, Peyman, et al.
Publicado: (2009)

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
por: Slaney, Clare Y., et al.
Publicado: (2013)

CHCHD2 connects mitochondrial metabolism to apoptosis
por: Liu, Yong, et al.
Publicado: (2015)

Modulating CD27 signaling to treat cancer
por: Riether, Carsten, et al.
Publicado: (2012)

A cancerous web: signaling, metabolism, and the epigenome
por: Lee, Joyce V., et al.
Publicado: (2014)

The emergence of phox-ER stress induced immunogenic apoptosis
por: Garg, Abhishek D., et al.
Publicado: (2012)

Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone
por: Riganti, Chiara, et al.
Publicado: (2013)

Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells
por: Wen, Xiangshu, et al.
Publicado: (2013)

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
por: Honeychurch, Jamie, et al.
Publicado: (2013)

Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012)

Inhibition of RANK signaling as a potential immunotherapy in breast cancer
por: Gómez-Aleza, C, et al.
Publicado: (2021)

Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis
por: Lizotte, Patrick H, et al.
Publicado: (2014)

Non-classical MHC Class I molecules regulating natural killer cell function
por: Smyth, Mark J., et al.
Publicado: (2013)

Dendritic cell-based vaccines: Shining the spotlight on signal 3
por: Linette, Gerald P, et al.
Publicado: (2013)

Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015)

Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
por: Shen, Li, et al.
Publicado: (2012)

The optogenetic promise for oncology: Episode I
por: Ingles-Prieto, Alvaro, et al.
Publicado: (2014)

Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells
por: Schilling, Bastian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vq42rb71d7a9nbv84eu7lqoh1s